Mortgage Blog
Richmond’s VetEvolve lands investment from Varsity Healthcare Partners
The local firm said it expected $70 million in 2022 revenue.
Ardelyx had sales team, launch plan ready to go before dialysis drug approval
Ardelyx Inc. CEO Mike Raab was pretty confident that his company's dialysis drug would be approved. By the time the U.S. Food and Drug Administration handed down its decision late Tuesday, Waltham-based Ardelyx had already hired around 60 salespeople.
M&T continues to shrink CRE loan portfolio, looks to grow other lending
The bank's commercial real estate loan portfolio continued to shrink in the third quarter as part of of the bank's ongoing effort to change its loan mix.
Equity Bancshares’ quarterly earnings, revenue beat analyst estimates
Despite topping Wall Street estimates, Equity Bancshares' earnings and revenue were both down year over year.
State Street stock rises after Q3 earnings call
State Street CEO Ronald O'Hanley told investors Wednesday that the bank faced economic headwinds this quarter, including global central bank rate hikes and investor concerns about a prolonged higher interest rate environment and an economic “hard landing.”
Businesses are staring down an insurance problem. It could be costly.
The price of many types of insurance is on the rise, but that's not the only insurance problem many small businesses are facing.
Columbus insuretech startup Matic doubles valuation with $20M raise
Founded in 2014, the digital insurance agency on average doubled revenue each of the last five years, according to a news release, and profit has increased by more than 60% over last year.
Citizens invests in private banking amid Q3 earnings slump
Citizens Financial Group is “playing defense and maintaining a strong balance sheet” as it navigates banking industry uncertainty, Citizens CEO and chairman Bruce Van Saun said Wednesday during a Q3 earnings call.
Jeff Smith named CEO of Bamboo Health, as an affiliated company raises nearly $14 million
The raise was made in “connection with a business combination transaction, such as a merger, acquisition or exchange offer.”
How an East Bay biotech is engineering bacteria to defeat cancer
Investors in the six-year-old company include Boehringer Ingelheim and Illumina Ventures.